RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. JDRF T1D Fund
J

JDRF T1D Fund portfolio

JDRF T1D Fund has 1 portfolio company on record at Recent Funding. It led 1 of the 2 rounds it joined. Its most recent investment on record is Biolinq's $100M Series B+ round in November 2021, alongside T&W Medical, The Broe Group, Taisho Pharmaceutical Holdings and 6 others. That company is in Health and bio. It has co-invested with M Ventures, Hikma Ventures and Senvest Management, most often M Ventures (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Rounds led: 1 of 2.
Capital in their rounds: $104.75M.
Latest deal: Biolinq · Nov 2, 2021.

What JDRF T1D Fund invests in

How JDRF T1D Fund invests

StageDealsCapital in rounds
Series A 1 50%$4.75M
Series B+ 1 50%$100M
YearDealsCapital in rounds
2019 1 50%$4.75M
2021 1 50%$100M

Share is of the 2 rounds on Recent Funding that name JDRF T1D Fund. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

JDRF T1D Fund portfolio companies

CompanyRound with JDRF T1D FundTotal raisedLatest raise
BBiolinq
Health and bio
 Series B+ · $100M$214.75MApr 22, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists JDRF T1D Fund, which is a subset of its real portfolio. API: /api/v1/investors/jdrf-t1d-fund (get a free API key). More: the most active VC firms and new venture capital funds.